NikaBiotech, driven by advanced research and technical expertise, introduced its first product, CytoGard, to the market. Containing avian cytokines, CytoGard successfully passed all specialized tests and scientific validations, earning recognition as a valuable biological supplement for enhancing poultry health and immunity.

Building on this success, our R&D team has launched a new development project: CytoGard Plus. This upgraded formulation is based on the original CytoGard but enhanced with a recombinant antibacterial peptide produced in our laboratory. The combination of these two bioactive agents results in a unique product designed not only to reduce inflammation and strengthen the immune system, but also to exert direct effects against gastrointestinal pathogens.

This innovation marks a significant step toward NikaBiotech’s mission to deliver scientific, sustainable, and effective solutions in biotechnology, opening new horizons for improving health and productivity in the poultry industry.